Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Tanner

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Scientific Reports|June 11, 2021
High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluationLaura Sibley, Andrew D White, Karen E Gooch, et al.
The Journal of Infectious Diseases|April 9, 2016
Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth ReductionTingting Chen, Caroline Blanc, Anke Z Eder, et al.
Nature Communications|May 29, 2025
Early mucosal responses following a randomised controlled human inhaled infection with attenuated Mycobacterium bovis BCGJulia L Marshall, Iman Satti, Mirvat Surakhy, et al.
The Lancet. Infectious Diseases|April 15, 2024
Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trialIman Satti, Julia L Marshall, Stephanie A Harris, et al.
JCI Insight|November 8, 2019
Cytomegalovirus infection is a risk factor for tuberculosis disease in infantsJulius Müller, Rachel Tanner, Magali Matsumiya, et al.
The Lancet. Microbe|May 4, 2024
Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection studySusan Jackson, Julia L Marshall, Andrew Mawer, et al.
Nature Communications|April 13, 2016
T-cell activation is an immune correlate of risk in BCG vaccinated infantsHelen A Fletcher, Margaret A Snowden, Bernard Landry, et al.
Nature Communications|May 7, 2016
Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infantsHelen A Fletcher, Margaret A Snowden, Bernard Landry, et al.
The Journal of Clinical Investigation|December 11, 2012
Vertical T cell immunodominance and epitope entropy determine HIV-1 escapeMichael K P Liu, Natalie Hawkins, Adam J Ritchie, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Scientific Reports|June 11, 2021
High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluationLaura Sibley, Andrew D White, Karen E Gooch, et al.
The Journal of Infectious Diseases|April 9, 2016
Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth ReductionTingting Chen, Caroline Blanc, Anke Z Eder, et al.
Nature Communications|May 29, 2025
Early mucosal responses following a randomised controlled human inhaled infection with attenuated Mycobacterium bovis BCGJulia L Marshall, Iman Satti, Mirvat Surakhy, et al.
The Lancet. Infectious Diseases|April 15, 2024
Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trialIman Satti, Julia L Marshall, Stephanie A Harris, et al.
JCI Insight|November 8, 2019
Cytomegalovirus infection is a risk factor for tuberculosis disease in infantsJulius Müller, Rachel Tanner, Magali Matsumiya, et al.
The Lancet. Microbe|May 4, 2024
Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection studySusan Jackson, Julia L Marshall, Andrew Mawer, et al.
Nature Communications|April 13, 2016
T-cell activation is an immune correlate of risk in BCG vaccinated infantsHelen A Fletcher, Margaret A Snowden, Bernard Landry, et al.
Nature Communications|May 7, 2016
Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infantsHelen A Fletcher, Margaret A Snowden, Bernard Landry, et al.
The Journal of Clinical Investigation|December 11, 2012
Vertical T cell immunodominance and epitope entropy determine HIV-1 escapeMichael K P Liu, Natalie Hawkins, Adam J Ritchie, et al.
Pageof 8